Thirdly, we need to ensure that C3N-Dbn-Trp2 and its derivatives can efficiently promote the killing of cancer cells with chemotherapeutic drugs while minimizing side effects on normal cells expressing ABCB1 in the body. Here, ABCB1 is linked to cancer.